Laminar Pharma is a biopharmaceutical company performing discovery, rational design and initial clinical development of new MLT-based drugs.
Laminar Pharma has raised $9.3M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in October 2023.
Laminar Pharma's investors include Capital Cell, OK Venture, Dentol Capital.
Laminar Pharma is headquartered in Palma De Mallorca, Spain.
Laminar Pharma is a biopharmaceutical company performing discovery, rational design and initial clinical development of new MLT-based drugs.
Laminar Pharma is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Laminar Pharma — Funding & Investors." VCBacked, October 5, 2023, https://www.vcbacked.co/company/laminar-pharma. Accessed September 25, 2026.
VCBacked. (2023). Laminar Pharma — Funding & Investors. Retrieved September 25, 2026, from https://www.vcbacked.co/company/laminar-pharma
{{cite web |title=Laminar Pharma — Funding & Investors |url=https://www.vcbacked.co/company/laminar-pharma |website=VCBacked |access-date=September 25, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated